Greater Birmingham has a strong and growing industry base of medical technologies and biopharma companies including large growth companies such as The Binding Site Group (immuno-diagnostics), Salts Healthcare Ltd, (stoma care) and Kimal (surgical packs) and a large number of innovative companies, including university spin-outs, across diagnostics, devices and digital health (e.g. Linear Diagnostics, Aston Eyetech and Safe Patient Systems).
Our life sciences cluster is based in excellence in science, manufacturing, digital and data technologies and leading capabilities in translational medicine and clinical trials. The region has numerous centres of national and international significance including the largest national Cancer Research UK Clinical Trials Unit, the NIHR Trauma Management MedTech Cooperative (Trauma MIC), one of six national Health Data Research UK sites, one of four Midlands & Wales Advanced Therapy Treatment Centres, the West Midlands Genomic Medicine Centre and Aston Brain Centre.
We offer a rich and comprehensive ecosystem for healthcare innovation with strong translational partnerships across academia, the NHS and industry – most notably Birmingham Health Partners – and specialist incubation and industry-facing support such as the MD-TEC Medical Devices Testing and Evaluation Centre at the Institute of Translational Medicine.
Birmingham’s Life Sciences Park, due to open in 2022, will harness world-leading academic and clinical strengths while bringing new commercial power to the region to accelerate life sciences research, taking innovative new healthcare treatments and technologies from early development to real life application.
GBSLEP is working with industry, the NHS and academia across the West Midlands to ensure that our capabilities as a global centre for data-driven healthcare innovation are converted into higher levels of industry investment to drive inclusive growth based on higher levels of employment and better health outcomes for citizens.
The LEP itself has secured major investment for the development of key regional infrastructure including the Institute of Translational Medicine, Birmingham Life Sciences Park and MD-TEC and is investing in business support and skills to support the development of the industry cluster.
For more information, click here to read the LEP’s Strategic Economic Plan.